These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37220812)

  • 1. Disease Spectrum of Anaphylaxis Disorders.
    González de Olano D; Cain WV; Bernstein JA; Akin C
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):1989-1996. PubMed ID: 37220812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.
    Giannetti MP; Akin C; Castells M
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of mast cell clonality in patients with unexplained anaphylaxis.
    Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
    Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insect Sting Anaphylaxis-Or Mastocytosis-Or Something Else?
    Golden DBK; Carter MC
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1117-1123. PubMed ID: 30961837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell activation syndromes presenting as anaphylaxis.
    Akin C
    Immunol Allergy Clin North Am; 2015 May; 35(2):277-85. PubMed ID: 25841551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to interpret mast cell tests.
    Waterfield T; Dyer E; Wilson K; Boyle RJ
    Arch Dis Child Educ Pract Ed; 2016 Oct; 101(5):246-51. PubMed ID: 27325614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
    Kačar M; Rijavec M; Šelb J; Korošec P
    Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders.
    Zaghmout T; Maclachlan L; Bedi N; Gülen T
    J Allergy Clin Immunol Pract; 2024 Mar; 12(3):753-761. PubMed ID: 38056692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
    González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
    Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
    J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hymenoptera Allergy and Mast Cell Activation Syndromes.
    Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
    Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
    Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
    Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Mediator Symptoms, Allergy, and Anaphylaxis in Mastocytosis.
    Gulen T
    Immunol Allergy Clin North Am; 2023 Nov; 43(4):681-698. PubMed ID: 37758406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal hymenoptera venom anaphylaxis by undetected clonal mast cell disorder: A better identification of high risk patients is needed.
    Chatain C; Sedillot N; Thomas M; Pernollet M; Bocquet A; Boccon-Gibod I; Bouillet L; Leccia MT
    Rev Med Interne; 2021 Dec; 42(12):869-874. PubMed ID: 34776279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on idiopathic anaphylaxis.
    Calvani M
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27():52-53. PubMed ID: 35080312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
    Schwartz LB
    Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis and mast cell disease: what is the risk?
    Akin C
    Curr Allergy Asthma Rep; 2010 Jan; 10(1):34-8. PubMed ID: 20425512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylaxis and Mast Cell Disorders.
    Gülen T; Akin C
    Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
    Rama TA; Torrado I; Henriques AF; Sánchez-Muñoz L; Jara-Acevedo M; Navarro-Navarro P; Caldas C; Mayado A; Muñoz-González J; García-Montero A; Mollejo M; Redondo E; Garbán A; Moreira A; Órfão A; Álvarez-Twose I
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):908-919.e4. PubMed ID: 36535520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
    Shin H; Lyons JJ
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.